(CercleFinance.com) – Eurobio Scientific announces the acquisition of 100% of the capital and voting rights of the Dutch company Genome Diagnostics BV (GenDx) from its founder and its shareholders for an amount of 135 million euros.
Founded in 2005 in Utrecht (Netherlands), GenDx specializes in the molecular diagnosis of transplants by HLA typing of organs or patients as part of the evaluation of compatibility between donors and recipients.
This acquisition will enable Eurobio Scientific to complete its commercial portfolio in order to assess compatibility between donors and recipients in the context of organ and marrow transplants.
It will also allow it to strengthen its geographical footprint, mainly in Europe and the USA.
Copyright © 2022 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
